Down 55%, Is Pfizer a Good Dividend Stock to Buy on the Dip?
The past few years have been tough ones for investors holding shares of (NYSE: PFE). The Big Pharma stock is down by more than half from the peak it set in late 2021.
Pfizer's stock price was hammered, but that didn't prevent the company from meeting and raising its dividend commitment. Last December, the pharmaceutical company raised its payout for the 15th consecutive year.
Shares of Pfizer offer an eye-popping 6.1% dividend yield at recent prices. Is the stock a buy for income-seeking investors? To find out, we'll need to weigh its strengths against reasons to avoid the stock.
Source Fool.com
Pfizer Inc. Aktie
27,88 €
-1,97 %
Klares Buy-Übergewicht bei der Pfizer Inc. Aktie mit 29 zu 4 Einschätzungen.
Das von der Community festgelegte Kursziel für Pfizer Inc. von 41 € impliziert eine deutliche Steigerung gegenüber dem aktuellen Kurs von 27.88 €.
